🇺🇸 FDA
Pipeline program

Alfuzosin

NMCSD CID 06-050

Phase 3 small_molecule active

Quick answer

Alfuzosin for Kidney Stones is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Kidney Stones
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials